DRUG · Mapped RxNorm record
letrozole
Normalized identity: letrozoleView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
NCT01194440
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
zoledronic acid
Normalized identity: zoledronic acidView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedZoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Stage I Breast Cancerunresolved
Stage II Breast Cancerunresolved
Stage IIIA Breast Cancerunresolved
Stage IIIB Breast Cancerunresolved
Stage IIIC Breast Cancerunresolved
Interventions
letrozoleDRUG · verified · RxNorm: letrozole
zoledronic acidDRUG · verified · RxNorm: zoledronic acid
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01194440 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.